Point72 Hong Kong LTD Gilead Sciences, Inc. Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$71.58 - $87.29 $688,384 - $839,467
9,617 New
9,617 $704,000
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $198,149 - $226,337
3,328 Added 164.1%
5,356 $330,000
Q2 2022

Aug 15, 2022
SELL
$57.72 - $65.01 $119,018 - $134,050
-2,062 Reduced 50.42%
2,028 $125,000
Q3 2021

Nov 15, 2021
SELL
$67.69 - $73.03 $1.58 Million - $1.71 Million
-23,354 Reduced 85.1%
4,090 $286,000
Q1 2021

May 17, 2021
BUY
$60.0 - $68.46 $246,600 - $281,370
4,110 Added 17.61%
27,444 $1.77 Million
Q3 2020

Nov 16, 2020
BUY
$62.1 - $78.08 $1.45 Million - $1.82 Million
23,334 New
23,334 $1.47 Million
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $158,758 - $178,029
-2,566 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $120,120 - $134,566
1,921 Added 297.83%
2,566 $167,000
Q4 2018

Feb 14, 2019
BUY
$60.54 - $79.0 $39,048 - $50,955
645 New
645 $40,000
Q2 2018

Aug 14, 2018
SELL
$64.88 - $75.68 $67,929 - $79,236
-1,047 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$72.84 - $88.8 $75,462 - $91,996
1,036 Added 9418.18%
1,047 $79,000
Q4 2017

Feb 14, 2018
SELL
$71.15 - $83.52 $211,315 - $248,054
-2,970 Reduced 99.63%
11 $1,000
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $214,959 - $254,786
2,981
2,981 $242,000

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email